| Sherri Caruso, CADC | |
|
3384 Motor Ave, Los Angeles, CA 90034-3712 | |
| (310) 721-8613 | |
| Not Available |
| Full Name | Sherri Caruso |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 3384 Motor Ave, Los Angeles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003268038 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sherri Caruso, CADC 5790 Valley Oak Dr, Los Angeles, CA 90068-3649 Ph: (310) 721-8613 | Sherri Caruso, CADC 3384 Motor Ave, Los Angeles, CA 90034-3712 Ph: (310) 721-8613 |
News Archive
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
From the critical moments after she suffered a gunshot wound to the head in January to her triumphant return to Congress last week for a vote on the debt-limit deal, Rep. Gabrielle Giffords owes her recovery in no small part to veterans with similar injuries.
Optimer Pharmaceuticals, Inc. announced that additional data related to fidaxomicin, the Company's lead developmental product candidate for the treatment of Clostridium difficile infection, will be presented at the 47th Annual Meeting of the Infectious Disease Society of America (IDSA) to be held at The Philadelphia Convention Center in Philadelphia, Pennsylvania October 29 through November 1, 2009.
Scientists at the Sol Goldman Pancreatic Cancer Research Center at the Johns Hopkins Kimmel Cancer Center have used "personalized genome" sequencing on an individual with a hereditary form of pancreatic cancer to locate a mutation in a gene called PALB2 that is responsible for initiating the disease.
› Verified 6 days ago
Angelica Oropeza, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1200 Wilshire Blvd, Los Angeles, CA 90017 Phone: 213-481-7464 Fax: 213-481-7147 | |
Tanya Sanderlin, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1147 S Alvarado St, Los Angeles, CA 90006 Phone: 213-381-8518 | |
Lionela Evers, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5151 S Western Ave, Los Angeles, CA 90062 Phone: 818-997-6876 | |
Lori Miller, Counselor Medicare: Not Enrolled in Medicare Practice Location: 600 E 7th St, Los Angeles, CA 90021 Phone: 213-537-0110 Fax: 213-537-0880 | |
Kesha Williams, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3761 Stocker St Ste 105, Los Angeles, CA 90008 Phone: 323-294-4261 | |
Genevieve Giselle Simari, PSY.D Counselor Medicare: Not Enrolled in Medicare Practice Location: 3787 S Vermont Ave, Los Angeles, CA 90007 Phone: 323-766-2345 | |
Sarah M. Powell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 12714 Avalon Blvd, Los Angeles, CA 90061 Phone: 323-242-5000 |